PriceTargets.com logo

Impact Healthcare REIT - IHR Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 114
  • Forecasted Upside: ∞
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 0 As of 10/21/2024 10:20 PM ET
+0 (0.00%)

This chart shows the closing price for IHR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Impact Healthcare REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for IHR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for IHR

Analyst Price Target is GBX 114
▲ +∞ Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Impact Healthcare REIT in the last 3 months. The average price target is GBX 114, with a high forecast of GBX 114 and a low forecast of GBX 114. The average price target represents a ∞ upside from the last price of GBX 0.

This chart shows the closing price for IHR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Impact Healthcare REIT.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/2/2024Jefferies Financial GroupReiterated RatingBuyGBX 114
6/6/2023Jefferies Financial GroupReiterated RatingBuyGBX 113
4/13/2023Royal Bank of CanadaReiterated RatingOutperformGBX 120
2/14/2023Royal Bank of CanadaLower TargetOutperformGBX 125 ➝ GBX 120
8/31/2022Berenberg BankReiterated RatingBuyGBX 135
5/13/2022Royal Bank of CanadaReiterated RatingOutperformGBX 140
4/12/2022Royal Bank of CanadaReiterated RatingOutperformGBX 135
4/8/2022Berenberg BankBoost TargetBuyGBX 125 ➝ GBX 135
3/24/2022Royal Bank of CanadaReiterated RatingOutperformGBX 135
3/11/2022Royal Bank of CanadaReiterated RatingOutperformGBX 135
5/6/2021Berenberg BankReiterated RatingBuyGBX 125
8/12/2020Berenberg BankReiterated RatingBuyGBX 110
5/12/2020Berenberg BankReiterated RatingBuyGBX 110
5/6/2020Berenberg BankReiterated RatingBuy
4/22/2020Berenberg BankReiterated RatingBuyGBX 110
2/6/2020Berenberg BankInitiated CoverageBuyGBX 130
(Data available from 12/26/2019 forward)

News Sentiment Rating

1.81 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/30/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/29/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2024
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2024

Current Sentiment

  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

Impact Healthcare REIT logo
Impact Healthcare REIT plc is a specialist and responsible owner of care homes and other healthcare properties across the UK. Elderly care is an essential service and demand for it is high and continues to grow as the UK's population gets older. We work with our tenants so we can grow together and help them care for more people, while continuing to improve our homes for their residents. We take a long-term view and look to generate secure and growing income. This has allowed us to provide our shareholders with attractive and rising dividends and the potential for capital growth. The target total dividend for the year ending 31 December 2023 is 6.77 pence per share, a 3.5% increase over the 6.54 pence in dividends paid per ordinary share for the year ended 31 December 2022. The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.
Read More

Today's Range

Now: N/A

50 Day Range

MA: GBX 87.69
Low: 87.30
High: 91.10

52 Week Range

Now: N/A

Volume

435,409 shs

Average Volume

629,312 shs

Market Capitalization

£361.75 million

P/E Ratio

793.64

Dividend Yield

7.73%

Beta

0.37

Frequently Asked Questions

What sell-side analysts currently cover shares of Impact Healthcare REIT?

The following sell-side analysts have issued research reports on Impact Healthcare REIT in the last twelve months: Jefferies Financial Group Inc..
View the latest analyst ratings for IHR.

What is the current price target for Impact Healthcare REIT?

0 Wall Street analysts have set twelve-month price targets for Impact Healthcare REIT in the last year. Their average twelve-month price target is GBX 114. Jefferies Financial Group Inc. has the highest price target set, predicting IHR will reach GBX 114 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of GBX 114 for Impact Healthcare REIT in the next year.
View the latest price targets for IHR.

What is the current consensus analyst rating for Impact Healthcare REIT?

Impact Healthcare REIT currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe IHR will outperform the market and that investors should add to their positions of Impact Healthcare REIT.
View the latest ratings for IHR.

What other companies compete with Impact Healthcare REIT?

Other companies that are similar to Impact Healthcare REIT include Primary Health Properties, Assura, Target Healthcare REIT, Life Science REIT and Medicx Fund. Learn More about companies similar to Impact Healthcare REIT.

How do I contact Impact Healthcare REIT's investor relations team?

Impact Healthcare REIT's physical mailing address is The Scalpel, 18th Floor, 52 Lime Street, London EC3M 7AF, United Kingdom. The company's listed phone number is 44 20 7409 0181. The official website for Impact Healthcare REIT is www.impactreit.uk. Learn More about contacing Impact Healthcare REIT investor relations.